Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/4145
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNicholas, L.en
dc.contributor.authorKausman, J.en
dc.contributor.authorAmelia, L. P.en
dc.contributor.authorMcCarthy, H.en
dc.contributor.authorFrancis, A.en
dc.contributor.authorPrestidge, C.en
dc.date.accessioned2022-11-07T23:49:48Z-
dc.date.available2022-11-07T23:49:48Z-
dc.date.issued2021en
dc.identifier.citation6, (4), 2021, p. S313en
dc.identifier.otherRISen
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/4145-
dc.description.abstractIntroduction: Limited data suggest that children with SRNS who were initially steroid sensitive (ISS) have an increased risk of recurrence post transplantation. ISS may be a proxy for those with circulating factor disease. There are no data on risk of transplant loss stratified by ISS. Methods: Children who received a kidney transplant between 2000 and 2019 for SRNS in 7 paediatric centres were included. Clinical data were gathered from chart reviews and transplant data were provided from ANZDATA following ethics approval. Transplant survival was estimated using the Kaplan-Meier estimator with Cox modelling used to explore predictors of survival. Results: There were 60 children who were transplanted for SRNS, 31 (51%) male, average age at transplant 11 years (SD 4) and 39 (65%) Caucasian. At presentation, 19/60 (32%) were steroid sensitive before becoming steroid resistant. Of the ISS group, 18/19 (95%) had recurrence post-transplant, compared to 17/41 (41%) of those always steroid resistant (p=0.001). The median time to recurrence was 3 days (inter quartile range 0-12 days), with no difference between the groups (p=0.9). Full remission after recurrence was achieved in 9/18 (50%) of the ISS group and 7/17 (42%) in the always steroid resistant group (p=0.64). Overall, 5-year transplant survival was 57% (95%CI 38-85%) in the ISS group, compared to 78% (95%CI 64-95%) in the always steroid resistant group (p=0.07) (Figure 1). [Formula presented] Conclusions: Initial steroid sensitivity is strongly associated with SRNS recurrence. Transplant survival for children with SRNS is poor with a non-significant trend to poorer outcomes for those with initial steroid sensitivity. Further research involving other cohorts is needed to assess if initial steroid sensitivity is associated with poorer graft outcomes. No conflict of interestL20116843542021-04-21 <br />en
dc.language.isoenen
dc.relation.ispartofKidney International Reportsen
dc.titlePOS-718 IMPACT OF INITIAL STEROID RESPONSE ON TRANSPLANT OUTCOMES IN CHILDREN WITH STEROID RESISTANT NEPHROTIC SYNDROMEen
dc.typeArticleen
dc.identifier.doi10.1016/j.ekir.2021.03.750en
dc.subject.keywordshuman tissueen
dc.subject.keywordsKaplan Meier methoden
dc.subject.keywordskidney graften
dc.subject.keywordsmajor clinical studyen
dc.subject.keywordsmaleen
dc.subject.keywordsmedical record reviewen
dc.subject.keywordsmulticenter studyen
dc.subject.keywordspediatric hospitalen
dc.subject.keywordsremissionen
dc.subject.keywordsschool childen
dc.subject.keywordsgraft survivalen
dc.subject.keywordsfemaleen
dc.subject.keywordsethicsen
dc.subject.keywordscontrolled studyen
dc.subject.keywordscongenital nephrotic syndromeen
dc.subject.keywordsconference abstracten
dc.subject.keywordschilden
dc.subject.keywordssteroidCaucasianen
dc.subject.keywordssurgeryen
dc.subject.keywordshumanen
dc.relation.urlhttps://www.embase.com/search/results?subaction=viewrecord&id=L2011684354&from=exporthttp://dx.doi.org/10.1016/j.ekir.2021.03.750 |en
dc.identifier.risid1832en
dc.description.pagesS313en
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeArticle-
Appears in Sites:Children's Health Queensland Publications
Show simple item record

Page view(s)

66
checked on Feb 14, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.